Vivos Inc. (OTCMKTS:RDGL - Get Free Report) was the target of a large growth in short interest in April. As of April 15th, there was short interest totalling 214,600 shares, a growth of 270.0% from the March 31st total of 58,000 shares. Currently, 0.1% of the shares of the stock are short sold. Based on an average daily volume of 1,637,700 shares, the days-to-cover ratio is presently 0.1 days.
Vivos Price Performance
Vivos stock traded down $0.00 during trading hours on Wednesday, hitting $0.14. The stock had a trading volume of 2,089,246 shares, compared to its average volume of 992,531. The stock has a market capitalization of $61.22 million, a price-to-earnings ratio of -13.50 and a beta of 0.88. Vivos has a 1-year low of $0.06 and a 1-year high of $0.26. The stock's fifty day moving average is $0.12 and its two-hundred day moving average is $0.12.
Vivos Company Profile
(
Get Free Report)
Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.
Featured Articles
Before you consider Vivos, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vivos wasn't on the list.
While Vivos currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.